全文获取类型
收费全文 | 8868篇 |
免费 | 453篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 130篇 |
妇产科学 | 76篇 |
基础医学 | 1158篇 |
口腔科学 | 218篇 |
临床医学 | 482篇 |
内科学 | 2234篇 |
皮肤病学 | 237篇 |
神经病学 | 728篇 |
特种医学 | 411篇 |
外科学 | 1687篇 |
综合类 | 51篇 |
一般理论 | 1篇 |
预防医学 | 202篇 |
眼科学 | 79篇 |
药学 | 462篇 |
中国医学 | 22篇 |
肿瘤学 | 1107篇 |
出版年
2024年 | 9篇 |
2023年 | 88篇 |
2022年 | 147篇 |
2021年 | 297篇 |
2020年 | 135篇 |
2019年 | 215篇 |
2018年 | 258篇 |
2017年 | 205篇 |
2016年 | 275篇 |
2015年 | 269篇 |
2014年 | 329篇 |
2013年 | 353篇 |
2012年 | 572篇 |
2011年 | 651篇 |
2010年 | 376篇 |
2009年 | 348篇 |
2008年 | 512篇 |
2007年 | 603篇 |
2006年 | 568篇 |
2005年 | 581篇 |
2004年 | 515篇 |
2003年 | 472篇 |
2002年 | 494篇 |
2001年 | 90篇 |
2000年 | 70篇 |
1999年 | 94篇 |
1998年 | 113篇 |
1997年 | 121篇 |
1996年 | 86篇 |
1995年 | 90篇 |
1994年 | 40篇 |
1993年 | 57篇 |
1992年 | 42篇 |
1991年 | 36篇 |
1990年 | 42篇 |
1989年 | 26篇 |
1988年 | 29篇 |
1987年 | 26篇 |
1986年 | 14篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1978年 | 11篇 |
1975年 | 4篇 |
1974年 | 7篇 |
1967年 | 5篇 |
排序方式: 共有9389条查询结果,搜索用时 0 毫秒
61.
62.
Incorporation of branched-chain fatty acid into cellular lipids and caspase-independent apoptosis in human breast cancer cell line,SKBR-3 总被引:1,自引:0,他引:1
Sawitree?Wongtangtintharn Hirosuke?OkuEmail author Hironori?Iwasaki Masashi?Inafuku Takayoshi?Toda Teruyoshi?Yanagita 《Lipids in health and disease》2005,4(1):29
Background
13-Methyltetradecanoic acid (13-MTD), an iso-C15 branched- chain saturated fatty acid, has been shown to induce apoptotic cell death of numerous human cancer cells. However, the mechanism for the induction of apoptosis has not been fully understood. This study described the incorporation of 13-MTD into cellular lipid of SKBR-3 breast cancer cells and apoptosis related event to gain more insight into the mechanism action of this fatty acid. 相似文献63.
Hirotoshi IMAMURA Shoichi TANI Hidemitsu ADACHI Ryu FUKUMITSU Tadashi SUNOHARA Nobuyuki FUKUI Yoshihiro OMURA Natsuhi SASAKI Tomoaki AKIYAMA Tatsumaru FUKUDA Shinji KAJIURA Masashi SHIGEYASU Kento ASAKURA Ryo HORII Nobuyuki SAKAI 《Neurologia medico-chirurgica》2022,62(5):223
Vasospasm, initial neurological damage, rebleeding, and periprocedural complications are associated prognostic factors for clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH). In this study, factors related to delayed ischemic neurological deficit (DIND) are evaluated using data from our institute for the last 18 years. Data from 2001 to 2018 of patients with aneurysmal SAH who underwent surgical clipping (SC) or endovascular coiling (EC) within 7 days of onset were retrospectively analyzed. Cases of mortality within 5 days after treatment were excluded. Multivariate analysis was used to identify the risk factors for DIND. In total, 840 cases of SAH were assessed; among these cases, 384 (45.7%) and 456 (54.3%) were treated with SC and EC, respectively. The frequency of DIND in the EC group was significantly less than that in the SC group (11.8% vs. 17.7%; p = 0.016). In the results of multivariate analysis, internal carotid artery (ICA) aneurysm and hemorrhagic complications were the risk factors for DIND. Cilostazol administration and EC were significant factors for vasospasm prevention after aneurysmal SAH (odds ratio of ICA aneurysm: 1.59, hemorrhagic complications: 1.76, SC: 1.51, and cilostazol administration: 0.51, respectively). Cilostazol administration was also a significant factor in patients who were treated with EC. ICA aneurysm, treatment strategy, hemorrhagic complications, and cilostazol administration were associated with DIND. Oral administration of cilostazol and avoiding hemorrhagic complications were effective in DIND prevention. If both treatments are available for ruptured aneurysms, clinicians should choose EC on the basis of its ability to prevent DIND. 相似文献
64.
Naoyuki Kanayama Fumiaki Isohashi Yasuo Yoshioka Sungjae Baek Masashi Chatani Tadayuki Kotsuma Eiichi Tanaka Ken Yoshida Yuji Seo Osamu Suzuki Seiji Mabuchi Yasuhiko Shiki Keiji Tatsumi Tadashi Kimura Teruki Teshima Kazuhiko Ogawa 《Journal of radiation research》2015,56(2):346-353
The purpose of this study was to determine the outcomes and optimal practice patterns of definitive radiotherapy for primary vaginal cancer. Between 1993 and 2012, 49 patients were treated with definitive radiotherapy for primary vaginal cancer in three hospitals. Of these, 15 patients (31%) had clinically positive regional lymph node metastasis. A total of 34 patients (70%) received external beam radiotherapy with high-dose-rate brachytherapy (interstitial or intracavitary), and 8 (16%) (with small superficial Stage I tumors) were treated with local radiotherapy. The median follow-up was 33 months (range: 1–169 months). The 3-year overall survival (OS), disease-free survival (DFS), and loco-regional control (LRC) rates were 83%, 59% and 71%, respectively. In multivariate analysis, the histological type (P = 0.044) was significant risk factors for LRC. In Federation of Gynecology and Obstetrics (FIGO) Stage I cases, 3 of 8 patients (38%) who did not undergo prophylactic lymph node irradiation had lymph node recurrence, compared with 2 of 12 patients (17%) who underwent prophylactic pelvic irradiation. For Stage III–IV tumors, the local recurrence rate was 50% and the lymph node recurrence rate was 40%. Patients with FIGO Stage I/II or clinical Stage N1 had a higher recurrence rate with treatment using a single modality compared with the recurrence rate using combined modalities. In conclusion, our treatment outcomes for vaginal cancer were acceptable, but external beam radiotherapy with brachytherapy (interstitial or intracavitary) was needed regardless of FIGO stage. Improvement of treatment outcomes in cases of FIGO Stage III or IV remains a significant challenge. 相似文献
65.
Yukari Nakajima Noriko Aramaki Kazuo Kishi Masashi Tamura Seishi Nakatsuka Masahiro Jinzaki Masanori Inoue 《Radiology Case Reports》2022,17(10):3591
An 80-year-old man underwent rectal resection and insertion of a central venous catheter through the left subclavian vein 16 years earlier. Following surgery, he developed edema of his left upper limb that became exacerbated and infected. Computed tomography showed occlusion of the subclavian vein and multiple arteriovenous shunts from the branches of the axillary artery to the venous sac of the axillary vein. Angiography confirmed numerous shunts between the branches of the axillary artery and vein and dilated collateral veins. Embolization of the venous sac was performed using coils, alcohol, and glue. Postprocedural angiography showed complete eradication of the nidus. 相似文献
66.
67.
Kamada T Koda M Dezawa M Yoshinaga K Hashimoto M Koshizuka S Nishio Y Moriya H Yamazaki M 《Journal of neuropathology and experimental neurology》2005,64(1):37-45
The aim of this study was to evaluate whether transplantation of Schwann cells derived from bone marrow stromal cells (BMSC-SCs) promotes axonal regeneration and functional recovery in completely transected spinal cord in adult rats. Bone marrow stromal cells (BMSCs) were induced to differentiate into Schwann cells in vitro. A 4-mm segment of rat spinal cord was removed completely at the T7 level. An ultra-filtration membrane tube, filled with a mixture of Matrigel (MG) and BMSC-SCs (BMSC-SC group) or Matrigel alone (MG group), was grafted into the gap. In the BMSC-SC group, the number of neurofilament- and tyrosine hydroxylase-immunoreactive nerve fibers was significantly higher compared to the MG group, although 5-hydroxytryptamine- or calcitonin gene-related peptide-immunoreactive fibers were rarely detectable in both groups. In the BMSC-SC group, significant recovery of the hindlimb function was recognized, which was abolished by retransection of the graft 6 weeks after transplantation. These results demonstrate that transplantation of BMSC-SCs promotes axonal regeneration of lesioned spinal cord, resulting in recovery of hindlimb function in rats. Transplantation of BMSC-SCs is a potentially useful treatment for spinal cord injury. 相似文献
68.
Takashi Harano Ernest G. Chan Masashi Furukawa Pedro Reck dos Santos Matthew R. Morrell Penny L. Sappington Pablo G. Sanchez 《Journal of thoracic disease》2022,14(4):832
BackgroundOxygenated right ventricular assist device (oxyRVAD) placement has become more streamlined with the introduction of the dual-lumen pulmonary artery cannula. Peripherally cannulated oxyRVAD may provide oxygenation support with right heart support as an alternative to venoarterial extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation.MethodsA single-institution, retrospective analysis was performed on patients placed on oxyRVAD with a dual-lumen pulmonary artery cannula with the intention of bridging to lung transplantation in 2019.ResultsFour patients with idiopathic pulmonary fibrosis were placed on oxyRVAD as a bridge to transplantation. Two patients were extubated and ambulated while waiting for a lung offer, and two patients required conversion to venoarteriovenous ECMO (VAV ECMO) from oxyRVAD. The median waiting time for extracorporeal life support (ECLS) was 42 h. All patients underwent double lung transplantation. Two patients stayed on oxyRVAD, and one patient was placed on venovenous ECMO (VV ECMO) after transplantation. Primary graft dysfunction score at 72 h after transplantation was grade 1 in three patients and grade 3 in one patient.ConclusionsPeripherally cannulated oxyRVAD with percutaneous dual-lumen venous cannula could be an ambulatory bridge for lung transplantation. It is unknown whether oxyRVAD is feasible as a long-term bridge to lung transplantation. 相似文献
69.
Naomi Takeichi Sanae Midorikawa Atsushi Watanabe Banyar Than Naing Hideki Tamura Toshiko Wakakuri‐Kano Akira Ishizaki Hitoshi Sugihara Sumiko Nissato Yuria Saito Yuichi Aita Kiyo‐aki Ishii Takehito Igarashi Yasushi Kawakami Hisato Hara Tatsuhiko Ikeda Kazuo Shimizu Shinichi Suzuki Hitoshi Shimano Masashi Kawamoto Takashi Shimada Tsuyoshi Watanabe Shinichi Oikawa Kazuhiro Takekoshi 《Clinical endocrinology》2012,77(5):707-714